Here, we report a patient with stage IIIA lung adenocarcinoma with a <i>RET</i> fusion gene and high expression of PD-L1 who underwent neoadjuvant chemoimmunotherapy and successfully attained a pathologic complete response. This evidence concerns the gene CD274 and lung adenocarcinoma.